TAK1 is required for TGF-β1-mediated regulation of matrix metalloproteinase-9 and metastasis
- 10 September 2007
- journal article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 27 (9), 1198-1207
- https://doi.org/10.1038/sj.onc.1210768
Abstract
Transforming growth factor-beta 1 (TGF-beta1) signaling in tumor cells has been implicated in tumor angiogenesis and metastasis by regulating matrix proteolysis. Although MMP-9/gelatinase-B is an important component of these TGF-beta1 responses, the mechanism of its regulation is not well understood. Here, we present evidence that TGF-beta-activated protein kinase 1 (TAK1) is critical for TGF-beta regulation of MMP-9 and the metastatic potential of breast cancer cell line MDA-MB-231. We found that suppression of TAK1 signaling by dominant-negative (dn) TAK1 or RNA interference (siRNA) reduces expression of MMP-9 and tumor cell invasion, without growth inhibition in cell culture. The orthotopic xenograft studies in SCID mice showed that suppression of TAK1 signaling by dn-TAK1 reduces tumor growth and formation of lung metastases. Dn-TAK1 reduced the proliferation Ki-67 index and neovasculature of orthotopic xenografts. TAK1-mediated regulation of MMP-9 involves NF-kappaB signaling. Dn-TAK1 reduces NF-kappaB transcriptional response and inhibition of NF-kappaB reduces expression of MMP-9 and activity of the MMP-9 promoter reporter. Together, these findings suggest that TAK1 contributes to TGF-beta1-mediated tumor angiogenesis and metastasis via a mechanism involving the TAK1-NF-kappaB-MMP-9 pathway.Keywords
This publication has 49 references indexed in Scilit:
- NF-κB: linking inflammation and immunity to cancer development and progressionNature Reviews Immunology, 2005
- Critical Roles of Threonine 187 Phosphorylation in Cellular Stress-induced Rapid and Transient Activation of Transforming Growth Factor-β-activated Kinase 1 (TAK1) in a Signaling Complex Containing TAK1-binding Protein TAB1 and TAB2Published by Elsevier BV ,2005
- Breast cancer cells with inhibition of p38<>α have decreased MMP-9 activity and exhibit decreased bone metastasis in miceClinical & Experimental Metastasis, 2004
- Smad-dependent and Smad-independent pathways in TGF-β family signallingNature, 2003
- Phosphatidylinositol 3-Kinase and NF-κB Regulate Motility of Invasive MDA-MB-231 Human Breast Cancer Cells by the Secretion of Urokinase-type Plasminogen ActivatorPublished by Elsevier BV ,2002
- Integrin β1 Signaling Is Necessary for Transforming Growth Factor-β Activation of p38MAPK and Epithelial PlasticityPublished by Elsevier BV ,2001
- Repression of transforming-growth-factor-β-mediated transcription by nuclear factor κBBiochemical Journal, 2000
- Urokinase Plasminogen Activator/Urokinase-specific Surface Receptor Expression and Matrix Invasion by Breast Cancer Cells Requires Constitutive p38α Mitogen-activated Protein Kinase ActivityPublished by Elsevier BV ,2000
- A mechanism of repression of TGFbeta / Smad signaling by oncogenic RasGenes & Development, 1999
- Transcriptional activation of the matrix metalloproteinase-9 gene in an H-ras and v-myc transformed rat embryo cell lineOncogene, 1997